Decker Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$368K Sell
2,467
-358
-13% -$50.2K 0.07% 95
2026
Q2
$357K Hold
2,825
– – 0.08% 88
2026
Q1
$394K Sell
2,825
-300
-10% -$42K 0.09% 80
2025
Q4
$384K Buy
+3,125
New +$380K 0.08% 82

Other funds holding GILD

Decker Wealth Management's GILD Position: Q3 2026 in Review

Decker Wealth Management reduced its Gilead Sciences (GILD) stake by 13% in Q3 2026, selling an estimated $50.2K and leaving 2,467 shares worth $368K. The position accounts for 0.07% of the portfolio, ranked #95.

Decker Wealth Management first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $394K in Q1 2026. 2,355 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Decker Wealth Management held 2,467 shares of Gilead Sciences worth $368K as of Q3 2026.
  • Decker Wealth Management sold 358 Gilead Sciences shares in Q3 2026, an estimated $50.2K.
  • Gilead Sciences made up 0.07% of Decker Wealth Management's portfolio in Q3 2026, its #95 holding.
  • Decker Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • Decker Wealth Management's Gilead Sciences position peaked at $394K in Q1 2026.
  • 2,355 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Decker Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.